Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model.

about

Inhibition of 5-lipoxygenase inhibitor zileuton in high-fat diet-induced nonalcoholic fatty liver disease progression model.

Item

http://www.wikidata.org/entity/Q47099295

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@en

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@nl

type

Item

label

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@en

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@nl

prefLabel

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@en

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@nl

P1476

Inhibition of 5-lipoxygenase i ...... ver disease progression model.

@en

P2093

Jing Miao

http://www.w3.org/2001/XMLSchema#string

Kuifen Ma

http://www.w3.org/2001/XMLSchema#string

Qingwei Zhao

http://www.w3.org/2001/XMLSchema#string

Xingguang Liang

http://www.w3.org/2001/XMLSchema#string

Yihe Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Antileukotrienes in upper airway inflammatory diseases

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease.

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis

Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.

The Serum Oxidative/Anti-oxidative Stress Balance Becomes Dysregulated in Patients with Non-alcoholic Steatohepatitis Associated with Hepatocellular Carcinoma.

The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.

Treatment of non-alcoholic fatty liver disease: can we already face the epidemic?

Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells.

P304

1207-1212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22038/IJBMS.2017.9482

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29299197

http://www.w3.org/2001/XMLSchema#string

P932

5749354

http://www.w3.org/2001/XMLSchema#string